List of Tables
Table 1. Global Circulating Tumor Cells Market Size Growth Rate by Type (US$ Million): (2017 VS 2021 VS 2028)
Table 2. Major Players of CTC Enrichment
Table 3. Major Players of CTC Detection
Table 4. Key Players of CTC Analysis
Table 5. Global Circulating Tumor Cells Market Size Growth by Application (2017 VS 2021 VS 2028)
Table 6. Global Circulating Tumor Cells Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Circulating Tumor Cells Revenue (US$ Million) Market Share by Region (2017-2022))
Table 8. Global Circulating Tumor Cells Revenue Share by Region (2017-2022)
Table 9. Global Circulating Tumor Cells Revenue (US$ Million) Forecast by Region (2023-2028)
Table 10. Global Circulating Tumor Cells Revenue Share Forecast by Region (2023-2028)
Table 11. Global Circulating Tumor Cells Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Circulating Tumor Cells Revenue Share by Players (2017-2022)
Table 13. Global Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells as of 2021)
Table 14. Ranking of Global Top Circulating Tumor Cells Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Circulating Tumor Cells Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Circulating Tumor Cells Product Solution and Service
Table 18. Date of Enter into Circulating Tumor Cells Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Circulating Tumor Cells Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Circulating Tumor Cells Revenue Market Share by Type (2017-2022)
Table 22. Global Circulating Tumor Cells Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Circulating Tumor Cells Revenue Market Share by Type (2023-2028)
Table 24. Global Circulating Tumor Cells Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Circulating Tumor Cells Revenue Market Share by Application (2017-2022)
Table 26. Global Circulating Tumor Cells Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Circulating Tumor Cells Revenue Market Share by Application (2023-2028)
Table 28. United States Circulating Tumor Cells Revenue by Company (2017-2022) & (US$ Million)
Table 29. United States Circulating Tumor Cells Revenue Market Share by Company (2017-2022)
Table 30. United States Circulating Tumor Cells Market Size by Type (2017-2022) & (K Units)
Table 31. United States Circulating Tumor Cells Market Size by Type (2023-2028) & (K Units)
Table 32. United States Circulating Tumor Cells Market Size by Application (2017-2022) & (K Units)
Table 33. United States Circulating Tumor Cells Market Size by Application (2023-2028) & (K Units)
Table 34. Europe Circulating Tumor Cells Revenue by Company (2017-2022) & (US$ Million)
Table 35. Europe Circulating Tumor Cells Revenue Market Share by Company (2017-2022)
Table 36. Europe Circulating Tumor Cells Market Size by Type (2017-2022) & (US$ Million)
Table 37. Europe Circulating Tumor Cells Market Size by Type (2023-2028) & (US$ Million)
Table 38. Europe Circulating Tumor Cells Market Size by Application (2017-2022) & (US$ Million)
Table 39. Europe Circulating Tumor Cells Market Size by Application (2023-2028) & (US$ Million)
Table 40. China Circulating Tumor Cells Revenue by Company (2017-2022) & (US$ Million)
Table 41. China Circulating Tumor Cells Revenue Market Share by Company (2017-2022)
Table 42. China Circulating Tumor Cells Market Size by Type (2017-2022) & (US$ Million)
Table 43. China Circulating Tumor Cells Market Size by Type (2023-2028) & (US$ Million)
Table 44. China Circulating Tumor Cells Market Size by Application (2017-2022) & (US$ Million)
Table 45. China Circulating Tumor Cells Market Size by Application (2023-2028) & (US$ Million)
Table 46. Japan Circulating Tumor Cells Revenue by Company (2017-2022) & (US$ Million)
Table 47. Japan Circulating Tumor Cells Revenue Market Share by Company (2017-2022)
Table 48. Japan Circulating Tumor Cells Market Size by Type (2017-2022) & (US$ Million)
Table 49. Japan Circulating Tumor Cells Market Size by Type (2023-2028) & (US$ Million)
Table 50. Japan Circulating Tumor Cells Market Size by Application (2017-2022) & (US$ Million)
Table 51. Japan Circulating Tumor Cells Market Size by Application (2023-2028) & (US$ Million)
Table 52. Southeast Asia Circulating Tumor Cells Revenue by Company (2017-2022) & (US$ Million)
Table 53. Southeast Asia Circulating Tumor Cells Revenue Market Share by Company (2017-2022)
Table 54. Southeast Asia Circulating Tumor Cells Market Size by Type (2017-2022) & (US$ Million)
Table 55. Southeast Asia Circulating Tumor Cells Market Size by Type (2023-2028) & (US$ Million)
Table 56. Southeast Asia Circulating Tumor Cells Market Size by Application (2017-2022) & (US$ Million)
Table 57. Southeast Asia Circulating Tumor Cells Market Size by Application (2023-2028) & (US$ Million)
Table 58. India Circulating Tumor Cells Revenue by Company (2017-2022) & (US$ Million)
Table 59. India Circulating Tumor Cells Revenue Market Share by Company (2017-2022)
Table 60. India Circulating Tumor Cells Market Size by Type (2017-2022) & (US$ Million)
Table 61. India Circulating Tumor Cells Market Size by Type (2023-2028) & (US$ Million)
Table 62. India Circulating Tumor Cells Market Size by Application (2017-2022) & (US$ Million)
Table 63. India Circulating Tumor Cells Market Size by Application (2023-2028) & (US$ Million)
Table 64. Menarini-Silicon Biosystems Company Details
Table 65. Menarini-Silicon Biosystems Description and Business Overview
Table 66. Menarini-Silicon Biosystems Circulating Tumor Cells Product
Table 67. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 68. Menarini-Silicon Biosystems Recent Development
Table 69. Qiagen (Adnagen) Company Details
Table 70. Qiagen (Adnagen) Description and Business Overview
Table 71. Qiagen (Adnagen) Circulating Tumor Cells Product
Table 72. Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 73. Qiagen (Adnagen) Recent Development
Table 74. Advanced Cell Diagnostics Company Details
Table 75. Advanced Cell Diagnostics Description and Business Overview
Table 76. Advanced Cell Diagnostics Circulating Tumor Cells Product
Table 77. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 78. Advanced Cell Diagnostics Recent Development
Table 79. ApoCell Company Details
Table 80. ApoCell Description and Business Overview
Table 81. ApoCell Circulating Tumor Cells Product
Table 82. ApoCell Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 83. ApoCell Recent Development
Table 84. Epic Sciences Company Details
Table 85. Epic Sciences Description and Business Overview
Table 86. Epic Sciences Circulating Tumor Cells Product
Table 87. Epic Sciences Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 88. Epic Sciences Recent Development
Table 89. Greiner Bio-one GmbH Company Details
Table 90. Greiner Bio-one GmbH Description and Business Overview
Table 91. Greiner Bio-one GmbH Circulating Tumor Cells Product
Table 92. Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 93. Greiner Bio-one GmbH Recent Development
Table 94. Cynvenio Company Details
Table 95. Cynvenio Description and Business Overview
Table 96. Cynvenio Circulating Tumor Cells Product
Table 97. Cynvenio Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 98. Cynvenio Recent Development
Table 99. SurExamBio-Tech Company Details
Table 100. SurExamBio-Tech Circulating Tumor Cells Product
Table 101. SurExamBio-Tech Description and Business Overview
Table 102. SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 103. SurExamBio-Tech Recent Development
Table 104. Fluxion Biosciences Company Details
Table 105. Fluxion Biosciences Circulating Tumor Cells Product
Table 106. Fluxion Biosciences Description and Business Overview
Table 107. Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 108. Fluxion Biosciences Recent Development
Table 109. Ikonisys Company Details
Table 110. Ikonisys Description and Business Overview
Table 111. Ikonisys Circulating Tumor Cells Product
Table 112. Ikonisys Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 113. Ikonisys Recent Development
Table 114. Hangzhou Watson Biotech Company Details
Table 115. Hangzhou Watson Biotech Description and Business Overview
Table 116. Hangzhou Watson Biotech Circulating Tumor Cells Product
Table 117. Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 118. Hangzhou Watson Biotech Recent Development
Table 119. Biocept Company Details
Table 120. Biocept Description and Business Overview
Table 121. Biocept Circulating Tumor Cells Product
Table 122. Biocept Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 123. Biocept Recent Development
Table 124. CytoTrack Company Details
Table 125. CytoTrack Description and Business Overview
Table 126. CytoTrack Circulating Tumor Cells Product
Table 127. CytoTrack Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 128. CytoTrack Recent Development
Table 129. Guangzhou Wondfo Biotech Company Details
Table 130. Guangzhou Wondfo Biotech Description and Business Overview
Table 131. Guangzhou Wondfo Biotech Circulating Tumor Cells Product
Table 132. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 133. Guangzhou Wondfo Biotech Recent Development
Table 134. Celsee Company Details
Table 135. Celsee Description and Business Overview
Table 136. Celsee Circulating Tumor Cells Product
Table 137. Celsee Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 138. Celsee Recent Development
Table 139. Clearbridge Biomedics Company Details
Table 140. Clearbridge Biomedics Description and Business Overview
Table 141. Clearbridge Biomedics Circulating Tumor Cells Product
Table 142. Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 143. Clearbridge Biomedics Recent Development
Table 144. ANGLE plc Company Details
Table 145. ANGLE plc Description and Business Overview
Table 146. ANGLE plc Circulating Tumor Cells Product
Table 147. ANGLE plc Revenue in Circulating Tumor Cells Business (2017-2022) & (US$ Million)
Table 148. ANGLE plc Recent Development
Table 149. Circulating Tumor Cells Market Trends
Table 150. Circulating Tumor Cells Market Drivers
Table 151. Circulating Tumor Cells Market Challenges
Table 152. Circulating Tumor Cells Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells Market Share by Type: 2021 VS 2028
Figure 2. CTC Enrichment Features
Figure 3. CTC Detection Features
Figure 4. CTC Analysis Features
Figure 5. Global Circulating Tumor Cells Market Share by Application: 2021 VS 2028
Figure 6. Breast Cancer Case Studies
Figure 7. Prostate Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Circulating Tumor Cells Report Years Considered
Figure 12. Global Circulating Tumor Cells Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Circulating Tumor Cells Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Circulating Tumor Cells Revenue Market Share by Region: 2017 VS 2021
Figure 15. United States Circulating Tumor Cells Revenue (Million USD) Growth Rate (2017-2028)
Figure 16. Europe Circulating Tumor Cells Revenue (Million USD) Growth Rate (2017-2028)
Figure 17. China Circulating Tumor Cells Revenue (Million USD) Growth Rate (2017-2028)
Figure 18. Japan Circulating Tumor Cells Revenue (Million USD) Growth Rate (2017-2028)
Figure 19. Southeast Asia Circulating Tumor Cells Revenue (Million USD) Growth Rate (2017-2028)
Figure 20. India Circulating Tumor Cells Revenue (Million USD) Growth Rate (2017-2028)
Figure 21. Global Circulating Tumor Cells Market Share by Players in 2021
Figure 22. Global Top Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2021)
Figure 23. The Top 10 and 5 Players Market Share by Circulating Tumor Cells Revenue in 2021
Figure 24. United States Circulating Tumor Cells Market Share by Type (2017-2028)
Figure 25. United States Circulating Tumor Cells Market Share by Application (2017-2028)
Figure 26. Europe Circulating Tumor Cells Market Share by Type (2017-2028)
Figure 27. Europe Circulating Tumor Cells Market Share by Application (2017-2028)
Figure 28. China Circulating Tumor Cells Market Share by Type (2017-2028)
Figure 29. China Circulating Tumor Cells Market Share by Application (2017-2028)
Figure 30. Japan Circulating Tumor Cells Market Share by Type (2017-2028)
Figure 31. Japan Circulating Tumor Cells Market Share by Application (2017-2028)
Figure 32. Southeast Asia Circulating Tumor Cells Market Share by Type (2017-2028)
Figure 33. Southeast Asia Circulating Tumor Cells Market Share by Application (2017-2028)
Figure 34. India Circulating Tumor Cells Market Share by Type (2017-2028)
Figure 35. India Circulating Tumor Cells Market Share by Application (2017-2028)
Figure 36. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 37. Qiagen (Adnagen) Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 38. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 39. ApoCell Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 40. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 41. Greiner Bio-one GmbH Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 42. Cynvenio Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 43. SurExamBio-Tech Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 44. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 45. Ikonisys Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 46. Hangzhou Watson Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 47. Biocept Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 48. CytoTrack Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 49. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 50. Celsee Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 51. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 52. ANGLE plc Revenue Growth Rate in Circulating Tumor Cells Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
